# Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy

> **NCT06304896** · PHASE1 · UNKNOWN · sponsor: **Arab Contractors Medical Centre** · enrollment: 150 (estimated)

## Conditions studied

- Chemotherapy Induced Systolic Dysfunction

## Interventions

- **DRUG:** Carvedilol
- **DRUG:** Ramipril
- **DRUG:** Rosuvastatin
- **DRUG:** Colchicine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06304896
- **Lead sponsor:** Arab Contractors Medical Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06304896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06304896, "Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06304896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*